Evolent Health, Inc

Historical 13F Holders

Symbol
EVH
CUSIP
30050B101
All holders as of
Q2 2026
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 30050B101 since 12/18/2024, largest first.

Filer % of Class Filed
Cadian Capital Management, LP 13G
9.3% 5/15/2025
Event 3/31/2025
BlackRock Portfolio Management LLC 13G 5.5% 7/17/2026
Event 6/30/2026
Boehler Adam 13G
5.2% 11/14/2025
Event 11/13/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
RA Capital Management, L.P. 13G/A
3.1% 2/14/2025
Event 12/31/2024
Morgan Stanley 13G/A
2.7% 9/8/2026
Event 8/31/2026
FMR LLC 13G/A
0.7% 2/5/2026
Event 12/31/2025
Wellington Management Group LLP 13G/A
0.4% 7/7/2025
Event 6/30/2025
Eventide Asset Management, LLC 13G/A
0% 2/13/2026
Event 12/31/2025
Durable Capital Partners LP 13G/A 0% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 280 k $979 k
2026 Q2 206 112 M $610 M
2026 Q1 198 111 M $253 M
2025 Q4 229 121 M $483 M
2025 Q3 254 140 M $1.18 B
2025 Q2 232 134 M $1.51 B
2025 Q1 245 127 M $1.20 B
2024 Q4 268 122 M $1.37 B
2024 Q3 302 134 M $3.77 B
2024 Q2 264 135 M $2.57 B
2024 Q1 269 132 M $4.32 B
2023 Q4 251 134 M $4.41 B
2023 Q3 217 122 M $3.34 B
2023 Q2 228 118 M $3.55 B
2023 Q1 255 112 M $3.62 B
2022 Q4 247 103 M $2.90 B
2022 Q3 273 95.6 M $3.43 B
2022 Q2 225 89.7 M $2.76 B
2022 Q1 235 86.6 M $2.79 B
2021 Q4 230 84.8 M $2.35 B
2021 Q3 241 85.9 M $2.66 B
2021 Q2 192 83.0 M $1.75 B
2021 Q1 182 82.0 M $1.66 B
2020 Q4 180 85.6 M $1.37 B
2020 Q3 168 80.0 M $997 M
2020 Q2 148 73.5 M $522 M
2020 Q1 170 78.6 M $434 M
2019 Q4 191 85.4 M $773 M
2019 Q3 196 84.9 M $610 M
2019 Q2 212 80.2 M $637 M
2019 Q1 206 81.1 M $1.02 B
2018 Q4 201 85.3 M $1.70 B
2018 Q3 208 84.1 M $2.39 B
2018 Q2 189 81.6 M $1.72 B
2018 Q1 165 79.7 M $1.13 B
2017 Q4 165 77.3 M $951 M
2017 Q3 175 73.8 M $1.32 B
2017 Q2 175 62.0 M $1.57 B
2017 Q1 144 41.7 M $925 M
2016 Q4 123 29.6 M $438 M
2016 Q3 115 27.3 M $679 M
2016 Q2 81 18.1 M $347 M
2016 Q1 70 16.5 M $174 M
2015 Q4 71 16.1 M $195 M
2015 Q3 70 15.9 M $254 M
2015 Q2 63 14.8 M $288 M